CD19-Directed Monoclonal Antibodies

Name
CD19-Directed Monoclonal Antibodies
Accession Number
DBCAT005666
Description

Monoclonal antibody directed against the B-cell-specific membrane protein CD19 with potential immunostimulating and antineoplastic activities.

Drugs
DrugDrug Description
Loncastuximab tesirineAn antibody-drug conjugate used for the treatment of relapsed and refractory B-cell lymphomas.
Drugs & Drug Targets
DrugTargetType
Loncastuximab tesirineB-lymphocyte antigen CD19target
Loncastuximab tesirineP-glycoprotein 1transporter
Loncastuximab tesirineCytochrome P450 3A4enzyme
Loncastuximab tesirineCytochrome P450 3A5enzyme